Skip to main content

Stock of psychedelics company MindMed slides 50% after it sells fresh shares

Shares of psychedelics company Mind Medicine Inc. slid 50% Wednesday after the company priced a dilutive secondary offering of 7.1 million shares.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.